Immunoexpression of alpha-SMA and CD68 in native kidney biopsies

Romanian Journal of Morphology and Embryology

Volumn 53, Issue 4, 2012, Pages 1037-1042

  Jercan, Ofelia ^a   Penescu, M ^b   Malaescu D G H ^c  

^a UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

^b 'Carol Davila' Nephrology Hospital   (Romania)

^c Universitatea Constantin Brancusi din Targu Jiu   (Romania)

Author keywords

Chronic kidney disease; Fibrosis; Macrophage infiltration; Myofibroblast

Indexed keywords

ACTA2 PROTEIN, HUMAN; ACTIN; CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN;

ARTICLE; BIOPSY; BIOSYNTHESIS; CHRONIC KIDNEY FAILURE; FIBROBLAST; FIBROSIS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; INFLAMMATION; KIDNEY; METABOLISM; PATHOLOGY;

ACTINS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOPSY; FIBROBLASTS; FIBROSIS; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KIDNEY; RENAL INSUFFICIENCY, CHRONIC;

EID: 84872235025     PISSN: 12200522     EISSN: 20668279     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Strutz F, Müller GA, Interstitial pathomechanisms underlying progressive tubulointerstitial damage, Kidney Blood Press Res, 1999, 22(1-2):71-80.
2. Choi YJ, Chakraborty S, Nguyen V, Nguyen C, Kim BK, Shim SI, Suki WN, Truong LD, Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: altered expression of vascular endothelial growth factor, Hum Pathol, 2000, 31(12):1491-1497.
3. Gabbiani G, The biology of the myofibroblast, Kidney Int, 1992, 41(3):530-532.
4. Tang WW, Van GY, Qi M, Myofibroblast and alpha 1 (III) collagen expression in experimental tubulointerstitial nephritis, Kidney Int, 1997, 51(3):926-931.
5. Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, Gabbiani G, A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation, J Cell Biol, 1986, 103(6 Pt 2):2787-2796.
6. Desmoulière A, Redard M, Darby I, Gabbiani G, Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar, Am J Pathol, 1995, 146(1):56-66.
7. Eyden BP, The myofibroblast: a study of normal, reactive and neoplastic tissues, with an emphasis on ultrastructure. Part 2 - Tumours and tumour-like lesions, J Submicrosc Cytol Pathol, 2005, 37(3-4):231-296.
8. Yang J, Liu Y, Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis, Am J Pathol, 2001, 159(4):1465-1475.
9. Yang J, Liu Y, Blockage of tubular epithelial to myo-fibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis, J Am Soc Nephrol, 2002, 13(1):96-107.
10. El-Nahas AM, Plasticity of kidney cells: role in kidney remodeling and scarring, Kidney Int, 2003, 64(5):1553-1563.
11. Schaefer L, Macakova K, Raslik I, Micegova M, Gröne HJ, Schönherr E, Robenek H, Echtermeyer FG, Grässel S, Bruckner P, Schaefer RM, Iozzo RV, Kresse H, Absence of decorin adversely influences tubulointerstitial fibrosis of the obstructed kidney by enhanced apoptosis and increased inflammatory reaction, Am J Pathol, 2002, 160(3):1181-1191.
12. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D, A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group, Ann Intern Med, 1999, 130(6):461-470.
13. Lameire N, Jager K, Van Biesen W, de Bacquer D, Vanholder R, Chronic kidney disease: a European perspective, Kidney Int Suppl, 2005, 99:S30-S38.
14. Essawy M, Soylemezoglu O, Muchaneta-Kubara EC, Shortland J, Brown CB, el Nahas AM, Myofibroblasts and the progression of diabetic nephropathy, Nephrol Dial Transplant, 1997, 12(1):43-50.
15. Nadasdy T, Laszik Z, Blick KE, Johnson DL, Silva FG, Tubular atrophy in the end-stage kidney: a lectin and immunohistochemical study, Hum Pathol, 1994, 25(1):22-28.
16. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG, Evidence that fibroblasts derive from epithelium during tissue fibrosis, J Clin Invest, 2002, 110(3):341-350.
17. Strutz F, Okada H, Lo CW, Danoff T, Carone RL, Tomaszewski JE, Neilson EG, Identification and characterization of a fibroblast marker: FSP1, J Cell Biol, 1995, 130(2):393-405.
18. Rastaldi MP, Ferrario F, Giardino L, Dell'Antonio G, Grillo C, Grillo P, Strutz F, Müller GA, Colasanti G, D'Amico G, Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies, Kidney Int, 2002, 62(1):137-146.
19. Tsakas S, Goumenos DS, Accurate measurement and clinical significance of urinary transforming growth factor-beta1, Am J Nephrol, 2006, 26(2):186-193.
20. Bagnasco S, Racusen L, Proteinuria and epithelial-to-mesenchymal transition: the role of complement, J Am Soc Nephrol, 2009, 20(3):459-460.
21. Abbate M, Zoja C, Remuzzi G, How does proteinuria cause progressive renal damage? J Am Soc Nephrol, 2006, 17(11):2974-2984.
22. Mengel M, Reeve J, Bunnag S, Einecke G, Sis B, Mueller T, Kaplan B, Halloran PF, Molecular correlates of scarring in kidney transplants: the emergence of mast cell transcripts, Am J Transplant, 2009, 9(1):169-178.
23. Pilmore HL, Painter DM, Bishop GA, McCaughan GW, Eris JM, Early up-regulation of macrophages and myo-fibroblasts: a new marker for development of chronic renal allograft rejection, Transplantation, 2000, 69(12):2658-2662.
24. Mandache E, Gherghiceanu M, Serafinceanu C, Penescu M, Mircescu G, Myofibroblast involvement in tubular basement membrane remodeling in type II diabetic nephropathy, Rom J Morphol Embryol, 2011, 52(1):75-79.
25. Mandache E, Penescu M, Renal subcapsular tertiary lymphoid aggregates in chronic kidney diseases, Rom J Morphol Embryol, 2011, 52(4):1219-1225.
26. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Chapman JR, Allen RD, Delta analysis of posttransplantation tubulointerstitial damage, Transplantation, 2004, 78(3):434-441.
27. Weitkamp B, Cullen P, Plenz G, Robenek H, Rauterberg J, Human macrophages synthesize type VIII collagen in vitro and in the atherosclerotic plaque, FASEB J, 1999, 13(11): 1445-1457.
28. Wyburn K, Wu H, Yin J, Jose M, Eris J, Chadban S, Macrophage-derived interleukin-18 in experimental renal allograft rejection, Nephrol Dial Transplant, 2005, 20(4):699-706.
29. Nishida M, Fujinaka H, Matsusaka T, Price J, Kon V, Fogo AB, Davidson JM, Linton MF, Fazio S, Homma T, Yoshida H, Ichikawa I, Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis, J Clin Invest, 2002, 110(12):1859-1868.
30. Vignery A, Osteoclasts and giant cells: macrophage- macrophage fusion mechanism, Int J Exp Pathol, 2000, 81(5):291-304.
31. Anders HJ, Frink M, Linde Y, Banas B, Wörnle M, Cohen CD, Vielhauer V, Nelson PJ, Gröne HJ, Schlöndorff D, CC chemokine ligand 5/RANTES chemokine antagonists aggravate glomerulonephritis despite reduction of glomerular leukocyte infiltration, J Immunol, 2003, 170(11):5658-5666.
32. Yang J, Reutzel-Selke A, Steier C, Jurisch A, Tullius SG, Sawitzki B, Kolls J, Volk HD, Ritter T, Targeting of macrophage activity by adenovirus-mediated intragraft overexpression of TNFRp55-Ig, IL-12p40, and vIL-10 ameliorates adenovirus-mediated chronic graft injury, whereas stimulation of macrophages by overexpression of IFN-gamma accelerates chronic graft injury in a rat renal allograft model, J Am Soc Nephrol, 2003, 14(1):214-225.
33. Camargo FD, Chambers SM, Goodell MA, Stem cell plasticity: from transdifferentiation to macrophage fusion, Cell Prolif, 2004, 37(1):55-65.
34. Bailey AS, Willenbring H, Jiang S, Anderson DA, Schroeder DA, Wong MH, Grompe M, Fleming WH, Myeloid lineage progenitors give rise to vascular endothelium, Proc Natl Acad Sci USA, 2006, 103(35): 13156-13161.